Givaudan SA (OTCMKTS:GVDNY - Get Free Report)'s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $87.47 and traded as high as $87.75. Givaudan shares last traded at $87.63, with a volume of 37,295 shares traded.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on GVDNY shares. Barclays cut shares of Givaudan from a "hold" rating to a "strong sell" rating in a report on Friday, November 15th. Citigroup cut shares of Givaudan from a "buy" rating to a "neutral" rating in a report on Thursday, October 17th.
Check Out Our Latest Analysis on GVDNY
Givaudan Price Performance
The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.94 and a current ratio of 1.43. The company's 50-day moving average price is $87.47 and its two-hundred day moving average price is $95.37.
About Givaudan
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
See Also
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
